Literature DB >> 11140785

Pharmacotherapy of disorders in mental retardation.

M G Aman1, A Collier-Crespin, R L Lindsay.   

Abstract

This is a review of pharmacotherapy in children and adolescents with mental retardation from the perspective of DSM and ICD disorders. The existing research is reviewed in young people with mental retardation but, when data are lacking, we examined the literature from adults with mental retardation and from typically-developing children. The literature is discussed for each of the following disorders: ADHD, anxiety disorders, bipolar disorder, conduct disorder, depression, enuresis, schizophrenia, self injury, and tics and movement disorders. With the possible exception of ADHD, there is a woeful lack of empirical data on most of these disorders in young people with mental retardation. Clinicians will often be forced to extrapolate from data on adults having mental retardation and from typically-developing children. The best policy is probably to treat such patients cautiously, while gathering data on the effects of such therapy in the hopes of beginning a data base.

Entities:  

Mesh:

Year:  2000        PMID: 11140785     DOI: 10.1007/s007870070023

Source DB:  PubMed          Journal:  Eur Child Adolesc Psychiatry        ISSN: 1018-8827            Impact factor:   4.785


  40 in total

1.  Midazolam for aggressivity and violence in three mentally retarded patients.

Authors:  W S Bond; L A Mandos; M B Kurtz
Journal:  Am J Psychiatry       Date:  1989-07       Impact factor: 18.112

2.  Long-term experience with lithium treatment in childhood: correlation with clinical diagnosis.

Authors:  G R DeLong; A L Aldershof
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1987-05       Impact factor: 8.829

3.  Overview of pharmacotherapy: current status and future directions.

Authors:  M G Aman
Journal:  J Ment Defic Res       Date:  1987-06

4.  Neuroleptic use, parkinsonian symptoms, tardive dyskinesia, and associated factors in child and adolescent psychiatric patients.

Authors:  M A Richardson; G Haugland; T J Craig
Journal:  Am J Psychiatry       Date:  1991-10       Impact factor: 18.112

5.  Buspirone treatment of aggression and anxiety in mentally retarded patients: a multiple-baseline, placebo lead-in study.

Authors:  J Ratey; R Sovner; A Parks; K Rogentine
Journal:  J Clin Psychiatry       Date:  1991-04       Impact factor: 4.384

6.  Clinical and economic aspects of risperidone treatment in adults with mental retardation and behavioral disturbance.

Authors:  R S Lott; J M Kerrick; S A Cohen
Journal:  Psychopharmacol Bull       Date:  1996

7.  Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndrome.

Authors:  E Shapiro; A K Shapiro; G Fulop; M Hubbard; J Mandeli; J Nordlie; R A Phillips
Journal:  Arch Gen Psychiatry       Date:  1989-08

8.  Case study of neuroleptic-induced akathisia: important implications for individuals with mental retardation.

Authors:  E J Gross; H G Hull; G J Lytton; J A Hill; W C Piersel
Journal:  Am J Ment Retard       Date:  1993-07

Review 9.  Issues in the taxonomy of psychopathology in mental retardation.

Authors:  S L Einfeld; M Aman
Journal:  J Autism Dev Disord       Date:  1995-04

10.  A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression.

Authors:  G J Emslie; A J Rush; W A Weinberg; R A Kowatch; C W Hughes; T Carmody; J Rintelmann
Journal:  Arch Gen Psychiatry       Date:  1997-11
View more
  3 in total

1.  Drug utilisation by children and adolescents with mental retardation: a population study.

Authors:  H Tobi; T Scheers; K A Netjes; E J Mulder; A de Bildt; R B Minderaa
Journal:  Eur J Clin Pharmacol       Date:  2005-05-20       Impact factor: 2.953

2.  ECT for self-injury in an autistic boy.

Authors:  Lee E Wachtel; Stephanie A Contrucci-Kuhn; Merrie Griffin; Ainsley Thompson; Dirk M Dhossche; Irving M Reti
Journal:  Eur Child Adolesc Psychiatry       Date:  2009-02-05       Impact factor: 4.785

Review 3.  Health promotion and disease prevention strategies in older adults with intellectual and developmental disabilities.

Authors:  Eli Carmeli; Bita Imam
Journal:  Front Public Health       Date:  2014-04-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.